Homology Medicines (LTS:0T6G) Marketable Securities : $43.39 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Homology Medicines Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Homology Medicines's Marketable Securities for the quarter that ended in Dec. 2023 was $43.39 Mil.

Homology Medicines's annual Marketable Securities increased from Dec. 2021 ($47.49 Mil) to Dec. 2022 ($141.04 Mil) but then declined from Dec. 2022 ($141.04 Mil) to Dec. 2023 ($43.39 Mil).

Homology Medicines Marketable Securities Historical Data

The historical data trend for Homology Medicines's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Homology Medicines Marketable Securities Chart

Homology Medicines Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

208.61

47.49

141.04

43.39

Homology Medicines Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Marketable Securities	Get a 7-Day Free Trial															141.04	110.57	50.27	74.19	43.39

Homology Medicines Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Homology Medicines (LTS:0T6G) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Homology Medicines Marketable Securities Related Terms

Thank you for viewing the detailed overview of Homology Medicines's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Homology Medicines (LTS:0T6G) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Homology Medicines Inc (LTS:0T6G) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

FIXX:USA 35H:Germany

Address

One Patriots Park, Bedford, MA, USA, 01730

Website

https://www.homologymedicines.com

Homology Medicines Inc is a United States-based genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a range of genetic disorders.

Homology Medicines (LTS:0T6G) Headlines

No Headlines